Appointments to Advisory Committee on Chinese Medicine Development Fund

image_pdfimage_print

     The Government announced today (February 26) the re-appointment of Mr Douglas So Cheung-tak as the Chairman of the Advisory Committee on Chinese Medicine Development Fund, the appointment of Dr Priscilla Choy Wai-fun as a new member, and the re-appointment of 13 incumbent members to the Committee.
 
     All appointments will take effect on March 1, 2021, for a term of two years.
 
     Since the establishment of the Chinese Medicine Development Fund (CMDF) in 2019, various funding schemes have been launched in phases to support training, improvement of clinic facilities, enhancement of proprietary Chinese medicine (pCm) manufacturing quality and management systems, pCm registration, promotion of Chinese medicine (CM), applied studies and research. The Committee has provided professional and valuable advice on matters relating to the scope, implementation, promotion and vetting of applications of these funding schemes. As at the end of 2020, over 900 funding applications had been approved.
 
     The Secretary for Food and Health, Professor Sophia Chan, thanked the Chairman and members of the Committee for their invaluable contributions over the past two years, and expressed the hope that the Committee could foster the development of CM in Hong Kong by continuing to offer views and recommendations on the overall administration and operation of the CMDF. Professor Chan also thanked the outgoing member, Ms Anne Chuah Ah-poh, and commended her contribution to the Committee.
 
     The membership of the Committee, with effect from March 1, 2021, is as follows:

Chairman
———–
Mr Douglas So Cheung-tak

Non-official Members
———–
Professor Bian Zhaoxiang
Dr Chan Kei-wai
Mr Chan Wing-suen
Dr Priscilla Choy Wai-fun
Professor Feng Yibin
Ms Lam Pui-yan
Ms Serena Lau Sze-wan
Mr Henry Lee Kai-ping
Dr Liong Ching
Mr Gerry Ma Kwai-yung
Dr Or Ka-hang
Ms Wang Huimin
Mr Wong Ka-on
Professor Justin Wu Che-yuen

Ex-officio Members
——————–
Representative(s) from the Food and Health Bureau
Representative(s) from the Department of Health
Representative(s) from the Hospital Authority
Representative(s) from the Innovation and Technology Commission 

Leave a Reply

Your email address will not be published.